Drugs / AIDSVAX® B/E
last change Dec 2014 re-read 2 minutes ago

AIDSVAX® B/E

Vaccine

Developed for
HIV infectious disease
Investigated by
HIV Vaccine Trials Network

Trials 1 · a red edge is where a trial was stopped

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01799954 Aug 2012 → Dec 2014 HIV infectious disease HIV Vaccine Trials Network Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as AIDSVAX B/E ClinicalTrials.gov intervention name — accepted as the source's own label NCT01799954
Modality Vaccine “boosting with the vaccines NYVAC and AIDSVAX® B/E” NCT01799954
Route Intramuscular “administered IM.” NCT01799954